Posts

Showing posts from June, 2025

high Lp(a) increases risk of recurrent ASCVD

  A recent study found that in patients with atherosclerotic cardiovascular disease (ASCVD), there was a progressive increase in recurrent cardiac events as lipoprotein(a) levels increased: see   Lp(a) recurrent ASCVD EuropHeartJ 2025  in dropbox. or   doi.org/10.1093/eurheartj/ehaf297 )   Details : -- they accessed the Family Heart Database of US medical claims from 340 million adults between 2012-2022, representing at least 1/2 of the national census population, with lipid data available for about 1/3 of them -- these medical claims included medication use, diagnoses, procedures, and surgeries     -- 273,770 people had diagnosed ASCVD as well as lipoprotein(a) levels, also referred to as Lp(a), measured         -- ASCVD was defined as: evidence of an MI, other acute coronary syndromes, percutaneous coronary interventions (PCI), CABG, stable angina, ischemic stroke, other cerebral vascular disease, TIA, peripheral va...